Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 21241 - 21260 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01FD02) pertuzumab | Perjeta 420 mg/14 mL injection, 14 mL vial | Solution for I.V. infusion 420 mg in 14 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheProductsPtyLtd |
| Australia | (L01FD02) pertuzumab | Perjeta 420 mg/14 mL injection, 14 mL vial | Solution for I.V. infusion 420 mg in 14 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheProductsPtyLtd |
| Australia | (L01FD02) pertuzumab | Perjeta 420 mg/14 mL injection, 14 mL vial | Solution for I.V. infusion 420 mg in 14 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheProductsPtyLtd |
| Australia | (L01FD03) trastuzumab emtansine | Kadcyla 100 mg powder for injection, 1 vial | Powder for I.V. infusion 100 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheProductsPtyLtd |
| Australia | (L01FD03) trastuzumab emtansine | Kadcyla 100 mg powder for injection, 1 vial | Powder for I.V. infusion 100 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheProductsPtyLtd |
| Australia | (L01FD03) trastuzumab emtansine | Kadcyla 100 mg powder for injection, 1 vial | Powder for I.V. infusion 100 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheProductsPtyLtd |
| Australia | (L01FD03) trastuzumab emtansine | Kadcyla 100 mg powder for injection, 1 vial | Powder for I.V. infusion 100 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheProductsPtyLtd |
| Australia | (L01FD03) trastuzumab emtansine | Kadcyla 160 mg powder for injection, 1 vial | Powder for I.V. infusion 160 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheProductsPtyLtd |
| Australia | (L01FD03) trastuzumab emtansine | Kadcyla 160 mg powder for injection, 1 vial | Powder for I.V. infusion 160 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheProductsPtyLtd |
| Australia | (L01FD03) trastuzumab emtansine | Kadcyla 160 mg powder for injection, 1 vial | Powder for I.V. infusion 160 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheProductsPtyLtd |
| Australia | (L01FD03) trastuzumab emtansine | Kadcyla 160 mg powder for injection, 1 vial | Powder for I.V. infusion 160 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheProductsPtyLtd |
| Australia | (L01FD04) trastuzumab deruxtecan | Enhertu 100 mg powder for injection, 1 vial | Powder for I.V. infusion 100 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | AstraZenecaPtyLtd |
| Australia | (L01FD04) trastuzumab deruxtecan | Enhertu 100 mg powder for injection, 1 vial | Powder for I.V. infusion 100 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | AstraZenecaPtyLtd |
| Australia | (L01FD04) trastuzumab deruxtecan | Enhertu 100 mg powder for injection, 1 vial | Powder for I.V. infusion 100 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | AstraZenecaPtyLtd |
| Australia | (L01FD04) trastuzumab deruxtecan | Enhertu 100 mg powder for injection, 1 vial | Powder for I.V. infusion 100 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | AstraZenecaPtyLtd |
| Australia | (L01FE01) cetuximab | Erbitux 100 mg/20 mL injection, 20 mL vial | Solution for I.V. infusion 100 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Colorectal Neoplasms | MerckHealthcarePtyLtd |
| Australia | (L01FE01) cetuximab | Erbitux 100 mg/20 mL injection, 20 mL vial | Solution for I.V. infusion 100 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Colorectal Neoplasms | MerckHealthcarePtyLtd |
| Australia | (L01FE01) cetuximab | Erbitux 100 mg/20 mL injection, 20 mL vial | Solution for I.V. infusion 100 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Colorectal Neoplasms | MerckHealthcarePtyLtd |
| Australia | (L01FE01) cetuximab | Erbitux 100 mg/20 mL injection, 20 mL vial | Solution for I.V. infusion 100 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Colorectal Neoplasms | MerckHealthcarePtyLtd |
| Australia | (L01FE01) cetuximab | Erbitux 100 mg/20 mL injection, 20 mL vial | Solution for I.V. infusion 100 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Colorectal Neoplasms | MerckHealthcarePtyLtd |
Pages
